Policy | July 11, 2025
EU launches strategies to strengthen crisis readiness and health security
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Xtandi is approved in over 80 countries, including the U.S., EU, and Japan
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
The facility will manufacture 13,200 MTPA Benzyl Chloride, 9,600 MTPA Benzyl Alcohol, and 7,200 MTPA Benzaldehyde
New findings reveal bemarituzumab plus chemotherapy significantly improves survival in advanced gastric cancer, offering hope for targeted treatment options
The collaboration aims to enhance the accuracy of physics-based methods with AI models for optimising small molecule medicine discovery and development
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
The company's decision to withdraw the MAA was due to the timing of the availability of Chemistry Manufacturing and Controls
Subscribe To Our Newsletter & Stay Updated
